YKL-40 tissue expression andplasma levels in patients with ovarian cancer.


YKL-40 (chitinase-3-like-1) is a member of "mammalian chitinase-like proteins". The protein is expressed in many types of cancer cells and the highest plasma YKL-40 levels have been found in patients with metastatic disease, short recurrence/progression-free intervals, and short overall survival.

The aim of the study was to determine the expression of YKL-40 in tumor tissue and plasma in patients with borderline ovarian tumor or epithelial ovarian cancer (OC), and investigate prognostic value of this marker.

Methods: YKL-40 protein expression was determined by immunohistochemistry in tissue arrays from 181 borderline tumors and 473 OC.

Plasma YKL-40 was determined by ELISA in preoperative samples from 19 patients with borderline tumor and 76 OC patients.

Results: YKL-40 protein expression was found in cancer cells, tumor associated macrophages, neutrophils and mast cells.

The tumor cell expression was higher in OC than in borderline tumors (p=0.001), and associated with FIGO stage (p<0.0001) and histological subtype (p=0.0009). Positive YKL-40 expression (>5% staining) was not associated with reduced survival.

Plasma YKL-40 was also higher in patients with OC than in patients with borderline tumors (p<0.0001), and it was positively correlated to serum CA-125 (p<0.0001) and FIGO stage (p=0.0001). Univariate Cox analysis of plasma YKL-40 showed association with overall survival (p<0.0001).

Multivariate Cox analysis, including plasma YKL-40, serum CA125, FIGO stage, age and radicality after primary surgery as variables, showed that elevated plasma YKL-40 was associated with a shorter survival (HR=2.13, 95% CI: 1.40-3.25, p=0.0004).

Conclusions: YKL-40 in OC tissue and plasma are related to stage and histology, but only plasma YKL-40 is a prognostic biomarker in patients with OC.



Published on: 2009-01-09

Made available by EUPB via SpringerOpen / BioMedCentral. Please make sure to read our disclaimer prior to contacting 7thSpace Interactive. To contact our editors, visit our online helpdesk. To submit your press release click here.

Discussions




Custom Search



Username
Password










© 2018 7thSpace Interactive
All Rights Reserved - About | Disclaimer | Helpdesk